<level>
  <type>section</type>
  <num>31-2993.02</num>
  <heading>Covered trials.</heading>
  <level>
    <num>(a)</num>
    <text>A health insurer shall not limit or deny coverage, or impose additional conditions on the payment for the coverage, of routine patient care costs of items, drugs, and services furnished to a qualified individual in connection with participation in an approved clinical trial. A health insurer shall not be required to pay for costs of items, services, or drugs that are customarily provided by the sponsors of an approved clinical trial.</text>
  </level>
  <level>
    <num>(b)</num>
    <text>In the case of health care services provided by a participating provider, the payment rate shall be at the network negotiated rate, based on the member's plan design. In case of a non-participating provider, the payment shall be at the rate that the member's plan would otherwise pay to a non-participating provider for the same services, less any applicable co-payments and deductibles.</text>
  </level>
  <level>
    <type>annotations</type>
    <level>
      <heading>History</heading>
      <text>(June 5, 2008, D.C. Law 17-166, ยง 3, 55 DCR 5174.)</text>
    </level>
    <level>
      <heading>Legislative History of Law 17-166</heading>
      <text>For Law 17-166, see notes following ยง 31-2993.01.</text>
    </level>
  </level>
</level>
